Cargando…

Diagnostic Accuracy of Two Molecular Tools for Diagnosis of Congenital Chagas Disease

BACKGROUND AND OBJECTIVE: The real prevalence of congenital Chagas disease is undefined because of difficulties in the detection of Trypanosoma cruzi by microscopic examination. The aim of this study was to determine the diagnostic accuracy of two molecular diagnostic tools, qPCR and LAMP, in the di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bisio, Margarita María Catalina, Rivero, Rocío, Gonzalez, Nicolás, Ballering, Griselda, D’Amico, Indira, Kessler, Camila, Moroni, Samanta, Moscatelli, Guillermo, Ruiz, Andrés Mariano, Altcheh, Jaime
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382099/ https://www.ncbi.nlm.nih.gov/pubmed/34426953 http://dx.doi.org/10.1007/s40291-021-00553-3

Ejemplares similares

Prevention of congenital Chagas through treatment of girls and women of childbearing age
por: Moscatelli, Guillermo, et al.
Publicado: (2015)

Negligible exposure to nifurtimox through breast milk during maternal treatment for Chagas Disease
por: Moroni, Samanta, et al.
Publicado: (2019)

Longitudinal follow up of serological response in children treated for Chagas disease
por: Moscatelli, Guillermo, et al.
Publicado: (2019)

Population Pharmacokinetic Study of Benznidazole in Pediatric Chagas Disease Suggests Efficacy despite Lower Plasma Concentrations than in Adults
por: Altcheh, Jaime, et al.
Publicado: (2014)

Congenital syphilis in Argentina: Experience in a pediatric hospital
por: Garcia, Luciana Noemí, et al.
Publicado: (2021)

Evaluation of the Chagas Western Blot IgG Assay for the Diagnosis of Chagas Disease
por: Brossas, Jean-Yves, et al.
Publicado: (2021)

Urban Chagas disease in children and women in primary care centres in Buenos Aires, Argentina
por: Moscatelli, Guillermo, et al.
Publicado: (2015)

Long-term cardiology outcomes in children after early treatment for Chagas disease, an observational study
por: González, Nicolás Leonel, et al.
Publicado: (2022)

Abdominal Cystic Echinococcosis Treated with Albendazole. A Pediatric Cohort Study
por: Moroni, Samanta, et al.
Publicado: (2016)

Validation of Apolipoprotein A-1 and Fibronectin Fragments as Markers of Parasitological Cure for Congenital Chagas Disease in Children Treated With Benznidazole
por: Ruiz-Lancheros, Elizabeth, et al.
Publicado: (2018)

Effectiveness of Nifurtimox in the Treatment of Chagas Disease: a Long-Term Retrospective Cohort Study in Children and Adults
por: Falk, N., et al.
Publicado: (2022)

Accurate Real-Time PCR Strategy for Monitoring Bloodstream Parasitic Loads in Chagas Disease Patients
por: Duffy, Tomas, et al.
Publicado: (2009)

ELISA F29 –A therapeutic efficacy biomarker in Chagas disease: Evaluation in pediatric patients treated with nifurtimox and followed for 4 years post-treatment
por: Rivero, Rocio, et al.
Publicado: (2023)

The Trypanosoma cruzi Antigen and Epitope Atlas: antibody specificities in Chagas disease patients across the Americas
por: Ricci, Alejandro D., et al.
Publicado: (2023)

Benznidazole Treatment of Chagasic Encephalitis in Pregnant Woman with AIDS
por: Bisio, Margarita, et al.
Publicado: (2013)

Efficacy and Safety of Nifurtimox in Pediatric Patients with Chagas Disease: Results at 4-Year Follow-Up in a Prospective, Historically Controlled Study (CHICO SECURE)
por: Altcheh, Jaime, et al.
Publicado: (2023)

Prospective, historically controlled study to evaluate the efficacy and safety of a new paediatric formulation of nifurtimox in children aged 0 to 17 years with Chagas disease one year after treatment (CHICO)
por: Altcheh, Jaime, et al.
Publicado: (2021)

Population pharmacokinetics of benznidazole in neonates, infants and children using a new pediatric formulation
por: Altcheh, Jaime, et al.
Publicado: (2023)

Miltefosine and Benznidazole Combination Improve Anti-Trypanosoma cruzi In Vitro and In Vivo Efficacy
por: Gulin, Julián Ernesto Nicolás, et al.
Publicado: (2022)

Benznidazole Therapy Modulates Interferon-γ and M2 Muscarinic Receptor Autoantibody Responses in Trypanosoma cruzi-Infected Children
por: Cutrullis, Romina A., et al.
Publicado: (2011)

Congenital Chagas disease: Updated recommendations for prevention, diagnosis, treatment, and follow-up of newborns and siblings, girls, women of childbearing age, and pregnant women
por: Carlier, Yves, et al.
Publicado: (2019)

Biopharmaceutical Characteristics of Nifurtimox Tablets for Age‐ and Body Weight‐Adjusted Dosing in Patients With Chagas Disease
por: Stass, Heino, et al.
Publicado: (2020)

Eliminating congenital syphilis and congenital Chagas disease
por: Buekens, Pierre, et al.
Publicado: (2022)

Congenital Chagas disease: an update
por: Carlier, Yves, et al.
Publicado: (2015)

2128. Lack of Congenital Transmission in Infants Born of Female Patients with Chagas Disease who Became Pregnant During a Nifurtimox Study (CHICO and CHICO SECURE Study)
por: Jaime, A L T C H E H, et al.
Publicado: (2022)

Towards Chagas disease elimination: Neonatal screening for congenital transmission in rural communities
por: Pennington, Pamela Marie, et al.
Publicado: (2017)

Chagas' Disease: Pregnancy and Congenital Transmission
por: Cevallos, Ana María, et al.
Publicado: (2014)

Congenital Chagas’ disease transmission in the United States: Diagnosis in adulthood
por: Murillo, Jorge, et al.
Publicado: (2016)

Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes
por: Mucci, Juan, et al.
Publicado: (2017)

Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole
por: Fernández, Marisa Liliana, et al.
Publicado: (2016)

1386. Chagas Disease in Chile: an Old and Forgotten
por: Novoa, Catalina, et al.
Publicado: (2023)

Secretome analysis of Trypanosoma cruzi by proteomics studies
por: Brossas, Jean-Yves, et al.
Publicado: (2017)

Use of a Novel Chagas Urine Nanoparticle Test (Chunap) for Diagnosis of Congenital Chagas Disease
por: Castro-Sesquen, Yagahira E., et al.
Publicado: (2014)

Mother-to-Child Transmission of Congenital Chagas Disease, Japan
por: Imai, Kazuo, et al.
Publicado: (2014)

A Model for Chagas Disease with Oral and Congenital Transmission
por: Coffield, Daniel J., et al.
Publicado: (2013)

The CUIDA Chagas Project: towards the elimination of congenital transmission of Chagas disease in Bolivia, Brazil, Colombia, and Paraguay
por: de Sousa, Andréa Silvestre, et al.
Publicado: (2022)

Target Product Profile (TPP) for Chagas Disease Point-of-Care Diagnosis and Assessment of Response to Treatment
por: Porrás, Analía I., et al.
Publicado: (2015)

Congenital Transmission of Chagas Disease in Latin American Immigrants in Switzerland
por: Jackson, Yves, et al.
Publicado: (2009)

New Scenarios of Chagas Disease Transmission in Northern Colombia
por: Tovar Acero, Catalina, et al.
Publicado: (2017)

Management of congenital muscular dystrophies related to defects in the LMNA gene
por: Quijano-Roy, Susana, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qef6h7nlt413q3d6ugjbjir3vp